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Background
IgA Deficiency (IgAD) is the most common immunoglobu-
lin deficiency, with approximate incidence of 1 in 400 to
3000 individuals in general population. Selective IgA defi-
ciency is defined as serum IgA levels less than 7 mg/dL
with normal serum IgM and IgG levels. A subgroup of indi-
viduals, with more than 7 mg/dL but less than 30 mg/dL of
serum IgA, are defined as partial IgA deficient patients
(pIgAD). Many individuals with selective IgA deficiency are
clinically asymptomatic. However, some patients have
increased incidence of infections, mainly in respiratory and
intestinal tracts, as well as presence of atopy, autoimmunity
and cancer.
Methods
Records review from children and adults outpatients fol-
lowed at the Clinical Immunology and Allergy Division
at Hospital das Clinicas of FMUSP. All patients were
orally informed about the use of these clinical data. The
objective was to report the clinical data observed in a
cohort of IgAD patients followed between 1994 and 2014.
Results
The most common associated condition found was ato-
pic disease in about 60% of patients, specially rhinitis (in
tIgAD and pIgAD). Prevalence of recurrent infection was
36%: 20% of sinusitis, otitis and amigdalitis, 10% of recur-
rent pneumonia (more than twice in the last year) and
18% of recurrent diarrhea. Autoimmunity condition was
observed in 18% of the patients. Autoimmune diseases
detected were thyroiditis, autoimmune hemolytic anemia,
idiopathic thrombocytopenic purpura, rheumatoid arthri-
tis, celiac-like disease, systemic lupus, Sjögren’s disease,
juvenile rheumatoid arthritis, autoimmune hepatitis and
vitiligo. The most prevalent disease observed was thyroid
disease in about 13% of the patients. History of medica-
tion reaction was observed in 9% of them and contact
dermititis in 8%. About 9% of the IgAD patients had
malignancies or pre neoplastic conditions like MGUS
(monoclonal gamopathy with uncertain signifcance). It
was not possible to establish rate mortality among these
patients because many patients lost follow up for
unknown reasons, but so far, only one death was
reported, and was attributed to sepsis.
Conclusions
Total and partial IgAD has a broad spectrum of clinical
associations and further investigations to immunological
intervention may have clinical results.
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